novo nordisk weight loss - Search News

News

CEO of Novo Nordisk, maker of weight loss drug Wegovy

The New York Times · 2d

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Associated Press News on MSN · 2d

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Novo Nordisk CEO's surprise exit after setbacks in weight-loss market: Reaction

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

2d

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

5d

Why Weight-Loss Developer Stocks Tumbled on Tuesday

A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results